PATENT CLAIM ANALYSIS

Application Number: 15762670
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "218000"]

Abstract:
A series of substituted pyrazolo[1,5-a]pyrimidine and pyrazolo[1,5-a][1,3,5]-triazine derivatives of formula (I), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.

Claim (Index 6):
The compound of formula (I) as defined in  claim 1  as herein specifically disclosed in any one of the Examples.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 90.0
- Lexical Diversity: 1.38462
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15318422', '15318507', '16060486', '14357340', '13508956']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7941636781118877
- 35 USC 102 Novelty (BERT): 0.5467261016936561
- Combined Prediction Score: 0.7694199204700646
- Mean Citation Score: 379.267696
- Max Citation Score: 396.2881
- Similarity Product: 233.97897408170687

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test